Pre-symptomatic alterations in subcellular βCGRP distribution in motor neurons precede astrogliosis in ALS mice

Neurobiology of Disease

Volumn 35, Issue 2, 2009, Pages 286-295

  Ringer, Cornelia ^a   Weihe, Eberhard ^a   Schütz, Burkhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Astrocyte; CGRP; Neurodegeneration; Neuropeptide; Spinal cord; Superoxide dismutase 1

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; DISEASE COURSE; DISEASE MODEL; FEMALE; IMMUNOREACTIVITY; MALE; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NERVE CELL DEGENERATION; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYMPTOM;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; AXONS; CALCITONIN GENE-RELATED PEPTIDE; DENDRITES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOSIS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; NEUROMUSCULAR JUNCTION; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 67649505368     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.05.011     Document Type: Article

References (50)

1. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
2. Arvidsson U., Piehl F., Johnson H., Ulfhake B., Cullheim S., and Hokfelt T. The peptidergic motoneurone. Neuroreport 4 (1993) 849-856
3. Biber K., Neumann H., Inoue K., and Boddeke H.W. Neuronal 'on' and 'off' signals control microglia. Trends Neurosci. 30 (2007) 596-602
4. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
5. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
6. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
7. Daniels M.P. Intercellular communication that mediates formation of the neuromuscular junction. Mol. Neurobiol. 14 (1997) 143-170
8. Dumoulin F.L., Raivich G., Haas C.A., Lazar P., Reddington M., Streit W.J., and Kreutzberg G.W. Calcitonin gene-related peptide and peripheral nerve regeneration. Ann. N.Y. Acad. Sci. 657 (1992) 351-360
9. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
10. Fukuoka T., Tokunaga A., Kondo E., Miki K., Tachibana T., and Noguchi K. Differential regulation of alpha- and beta-CGRP mRNAs within oculomotor, trochlear, abducens, and trigeminal motoneurons in response to axotomy. Brain Res. Mol. Brain Res. 63 (1999) 304-315
11. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
12. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
13. Hanisch U.K., and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007) 1387-1394
14. Hegedus J., Putman C.T., and Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 28 (2007) 154-164
15. Higgins C.M., Jung C., and Xu Z. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 4 (2003) 16
16. Ishida-Yamamoto A., and Tohyama M. Calcitonin gene-related peptide in the nervous tissue. Prog. Neurobiol. 33 (1989) 335-386
17. Jaarsma D., Rognoni F., van Duijn W., Verspaget H.W., Haasdijk E.D., and Holstege J.C. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. 102 (2001) 293-305
18. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18 (1998) 3241-3250
19. Lazar P., Reddington M., Streit W., Raivich G., and Kreutzberg G.W. The action of calcitonin gene-related peptide on astrocyte morphology and cyclic AMP accumulation in astrocyte cultures from neonatal rat brain. Neurosci. Lett. 130 (1991) 99-102
20. Levine J.B., Kong J., Nadler M., and Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28 (1999) 215-224
21. Ludwig M., and Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 7 (2006) 126-136
22. Maragakis N.J., and Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2 (2006) 679-689
23. Monk P.N., and Shaw P.J. ALS: life and death in a bad neighborhood. Nat. Med. 12 (2006) 885-887
24. Morara S., Wang L.P., Filippov V., Dickerson I.M., Grohovaz F., Provini L., and Kettenmann H. Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices. Eur. J. Neurosci. 28 (2008) 2213-2220
25. Moreno M.J., Terron J.A., Stanimirovic D.B., Doods H., and Hamel E. Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture. Neuropharmacology 42 (2002) 270-280
26. Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., and Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5472-5477
27. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., and Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10 (2007) 615-622
28. Nohr D., Schafer M.K., Persson S., Romeo H., Nyberg F., Post C., Ekstrom G., and Weihe E. Calcitonin gene-related peptide gene expression in collagen-induced arthritis is differentially regulated in primary afferents and motoneurons: influence of glucocorticoids. Neuroscience 93 (1999) 759-773
29. Pehar M., Vargas M.R., Cassina P., Barbeito A.G., Beckman J.S., and Barbeito L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener. Dis. 2 (2005) 139-146
30. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9 (2006) 408-419
31. Quirion R., Van Rossum D., Dumont Y., St-Pierre S., and Fournier A. Characterization of CGRP1 and CGRP2 receptor subtypes. Ann. N.Y. Acad. Sci. 657 (1992) 88-105
32. Reddington M., Priller J., Treichel J., Haas C., and Kreutzberg G.W. Astrocytes and microglia as potential targets for calcitonin gene related peptide in the central nervous system. Can. J. Physiol. Pharmacol. 73 (1995) 1047-1049
33. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344 (2001) 1688-1700
34. Salmon A.M., Damaj I., Sekine S., Picciotto M.R., Marubio L., and Changeux J.P. Modulation of morphine analgesia in alphaCGRP mutant mice. Neuroreport 10 (1999) 849-854
35. Salmon A.M., Damaj M.I., Marubio L.M., Epping-Jordan M.P., Merlo-Pich E., and Changeux J.P. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nat. Neurosci. 4 (2001) 357-358
36. Sarasa M., Terrado J., Mengod G., Climent S., Muniesa P., and Palacios J.M. Differential expression of alpha-CGRP and beta-CGRP genes within hypoglossal motoneurons in response to axotomy. Brain Res. Mol. Brain Res. 35 (1996) 269-277
37. Sau D., De Biasi S., Vitellaro-Zuccarello L., Riso P., Guarnieri S., Porrini M., Simeoni S., Crippa V., Onesto E., Palazzolo I., Rusmini P., Bolzoni E., Bendotti C., and Poletti A. Mutation of SOD1 in ALS: a gain of a loss of function. Hum. Mol. Genet. 16 (2007) 1604-1618
38. Schutz B. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol. Dis. 20 (2005) 131-140
39. Schutz B., Chen L., Schafer M.K., Weihe E., and Eiden L.E. Somatomotor neuron-specific expression of the human cholinergic gene locus in transgenic mice. Neuroscience 96 (2000) 707-722
40. Schutz B., Mauer D., Salmon A.M., Changeux J.P., and Zimmer A. Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice. J. Comp. Neurol. 476 (2004) 32-43
41. Schutz B., Reimann J., Dumitrescu-Ozimek L., Kappes-Horn K., Landreth G.E., Schurmann B., Zimmer A., and Heneka M.T. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 25 (2005) 7805-7812
42. Stieber A., Gonatas J.O., and Gonatas N.K. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus. J. Neurol. Sci. 173 (2000) 53-62
43. Sumi H., Nagano S., Fujimura H., Kato S., and Sakoda S. Inverse correlation between the formation of mitochondria-derived vacuoles and Lewy-body-like hyaline inclusions in G93A superoxide-dismutase-transgenic mice. Acta Neuropathol. 112 (2006) 52-63
44. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., and Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9 (2006) 108-118
45. Van Den Bosch L., and Robberecht W. Crosstalk between astrocytes and motor neurons: what is the message?. Exp. Neurol. 211 (2008) 1-6
46. Weihe E., Nohr D., Schafer M.K., Persson S., Ekstrom G., Kallstrom J., Nyberg F., and Post C. Calcitonin gene related peptide gene expression in collagen-induced arthritis. Can. J. Physiol. Pharmacol. 73 (1995) 1015-1019
47. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11 (1997) 167-239
48. Xu Z., Jung C., Higgins C., Levine J., and Kong J. Mitochondrial degeneration in amyotrophic lateral sclerosis. J. Bioenerg. Biomembr. 36 (2004) 395-399
49. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., and Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11 (2008) 251-253
50. Zheng L.F., Wang R., Xu Y.Z., Yi X.N., Zhang J.W., and Zeng Z.C. Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries. Brain Res. 1187 (2008) 20-32